LEDGINs, non-catalytic site inhibitors of HIV-1 integrase: a patent review (2006 – 2014)

Author： Demeulemeester Jonas Chaltin Patrick Marchand Arnaud De Maeyer Marc Debyser Zeger Christ Frauke

ISSN： 1354-3776

Source： Expert Opinion on Therapeutic Patents, Vol.24, Iss.6, 2014-06, pp. : 609-632

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Novel HIV-1 non-nucleoside reverse transcriptase inhibitors: a patent review (2005 –– 2010)

By Zhan Peng Liu Xinyong

Expert Opinion on Therapeutic Patents, Vol. 21, Iss. 5, 2011-05 ,pp. : 717-796

Informa Healthcare

Access to resources Recommend Favorite

Small-molecule BACE1 inhibitors: a patent literature review (2006 – 2011)

By Probst Gary Xu Ying-zi

Expert Opinion on Therapeutic Patents, Vol. 22, Iss. 5, 2012-05 ,pp. : 511-540

Informa Healthcare

Access to resources Recommend Favorite

Plasminogen activator inhibitor-1 inhibitors: a patent review (2006 - present)

By Fortenberry Yolanda M

Expert Opinion on Therapeutic Patents, Vol. 23, Iss. 7, 2013-07 ,pp. : 801-815

Informa Healthcare

Access to resources Recommend Favorite

HIV-1 Integrase Inhibitors: An Emerging Clinical Reality

By Dayam Raveendra Al-Mawsawi Laith Q. Neamati Nouri

Drugs in R&D, Vol. 8, Iss. 3, 2007-01 ,pp. : 155-168

Adis International

Access to resources Recommend Favorite

Computational Studies of HIV-1 Integrase and its Inhibitors

Current Computer - Aided Drug Design, Vol. 3, Iss. 3, 2007-09 ,pp. : 160-190

Bentham Science Publishers

Access to resources Recommend Favorite